Clinical Efficacy of Bevacizumab Combined With Navigated Laser in Patients With Clinically Significant Macula Edema
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this is study is to assess the efficacy of navigated laser treatment in
reducing the number of anti-VEGF injections required to maintain visual gain obtained after
Bevacizumab compared to Bevacizumab alone in patients with clinically significant macular
edema (CSME).
This will be prospective, active-controlled study using Bevacizumab (Genentech, South San
Francisco CA) for intravitreal injections. Retinal photocoagulation will utilize the Navilas
Laser System (OD-OS GmbH, Teltow, Germany), which is an approved indication for this device.